TABLE 6.
S. pyogenes multistep selection results
Strain no. | Phenotype (resistance determinant)a | Antibioticb | Initial MIC (μg/ml) | Selected resistance |
Retest MIC (μg/ml)c after passages in subinhibitory concns of the following antibiotic and 10 antibiotic-free subcultures: |
|||||
---|---|---|---|---|---|---|---|---|---|---|
MIC (μg/ml) | No. of passages | CEM | AZI | CLA | TEL | CLI | ||||
2132 | Macrolide S | CEM | 0.008 | 0.016 | 50 | |||||
AZI | 0.06 | 1 | 28 | 0.016 | 1 | 0.25 | 0.03 | 0.03 | ||
CLA | 0.03 | 0.016 | 50 | |||||||
TEL | 0.008 | 0.03 | 50 | |||||||
CLI | 0.06 | 0.06 | 50 | |||||||
2368 | Macrolide R [erm(B)] | CEM | 1 | 8 | 18 | 8 | >64 | >64 | >64 | >64 |
AZI | >64 | NTd | NT | |||||||
CLA | >64 | NT | NT | |||||||
TEL | 8 | >64 | 6 | 0.5 | >64 | >64 | >64 | >64 | ||
CLI | >64 | NT | NT | |||||||
2094 | Macrolide R [erm(A)] | CEM | 0.03 | 0.25 | 43 | 0.25 | 4 | 8 | 0.5 | 0.06 |
AZI | 4 | >64 | 5 | 0.016 | >64 | 1 | 0.03 | 0.06 | ||
CLA | 0.5 | >64 | 6 | 0.016 | >64 | >64 | 0.03 | 0.06 | ||
TEL | 0.03 | 0.25 | 22 | 0.03 | >64 | 8 | 0.125 | >64 | ||
CLI | 0.06 | >64 | 34 | 0.03 | 16 | 1 | 0.03 | >64 | ||
2011 | Macrolide R [mef(A)] | CEM | 0.125 | 0.125 | 50 | |||||
AZI | 4 | 32 | 35 | 0.06 | 16 | 4 | 0.25 | 0.06 | ||
CLA | 4 | 8 | 50 | |||||||
TEL | 0.5 | 1 | 50 | |||||||
CLI | 0.06 | 0.06 | 50 | |||||||
237 | Macrolide R (L4 mutation) | CEM | 0.03 | 0.25 | 20 | 0.5 | 4 | 1 | 1 | 0.03 |
AZI | 4 | 8 | 50 | |||||||
CLA | 0.25 | 1 | 50 | |||||||
TEL | 0.06 | 0.125 | 50 | |||||||
CLI | 0.06 | 0.5 | 43 | 0.03 | 8 | 0.5 | 0.06 | 1 |
S, susceptible; R, resistant.
CEM, CEM-101; AZI, azithromycin; CLA, clarithromycin; TEL, telithromycin; CLI, clindamycin.
Boldface indicates cross-reactivity.
NT, not tested.